Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


54.063 EUR 0.477 0.87%

As of 03:46:25 ET on 04/02/2015.

Snapshot for Adocia (A89)

Open: 54.257 Day's Range: 54.063 - 54.257 Volume: 0
Previous Close: 54.540 52wk Range: 10.040 - 74.728 1-Yr Rtn: +298.40%

Stock Chart for A89

No chart data available.
  • A89:GR 54.257
  • 1D
  • 1M
  • 1Y
Interactive A89 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A89

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 242.4350
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 0.2230
Est. PEG Ratio -
Market Cap (M EUR) 369.83
Shares Outstanding (M) 6.84
30 Day Average Volume 113
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A89

No data available

Company Profile & Key Executives for A89

Adocia SAS is a biotechnology company. The Company researches and develops protein delivery products for wound healing and tissue regeneration based on growth factors. Adocia is specialized in insulin therapy and the treatment of the diabetic foot ulcer, one of the main complications of diabetes.

Gerard SoulaChairman/CEOValerie DanaguezianChief Financial Officer
Olivier SoulaDir:R&D/Deputy Gen MgrRemi SoulaDir:Business Development
More Company Profile & Key Executives for A89

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil